A German drugmaker bidding to get even bigger

<p>Bayer announces it will spend as much as $4 billion in the acquisition of a gene therapy company. Plus, what toymakers can expect with holiday gift-giving on the horizon. And, gig companies throw more than just money at a ballot initiative in California concerned with how workers are classified in the state.</p>